Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Change in Cash (2016 - 2021)

Phio Pharmaceuticals' Change in Cash history spans 10 years, with the latest figure at -$2.5 million for Q4 2021.

  • For Q4 2021, Change in Cash rose 5.79% year-over-year to -$2.5 million; the TTM value through Dec 2021 reached $9.8 million, up 34.24%, while the annual FY2025 figure was $15.6 million, 603.51% up from the prior year.
  • Change in Cash reached -$2.5 million in Q4 2021 per PHIO's latest filing, up from -$2.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $18.5 million in Q1 2021 to a low of -$3.3 million in Q2 2021.
  • Average Change in Cash over 5 years is $557550.0, with a median of -$2.0 million recorded in 2018.
  • Peak YoY movement for Change in Cash: tumbled 595.28% in 2017, then surged 734.28% in 2018.
  • A 5-year view of Change in Cash shows it stood at -$1.8 million in 2017, then soared by 734.28% to $11.6 million in 2018, then plummeted by 115.25% to -$1.8 million in 2019, then crashed by 47.83% to -$2.6 million in 2020, then increased by 5.79% to -$2.5 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Change in Cash are -$2.5 million (Q4 2021), -$2.9 million (Q3 2021), and -$3.3 million (Q2 2021).